• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
  • View Item
  •   LillOA Home
  • Liste des unités
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Maternal red blood cell alloimmunization ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique: Article original
DOI :
10.1111/trf.14542
PMID :
29512164
Permalink :
http://hdl.handle.net/20.500.12210/16811
Title :
Maternal red blood cell alloimmunization requiring intrauterine transfusion: a comparative study on management and outcome depending on the type of antibody
Author(s) :
Phung, Thanh-Vy [Auteur]
Debarge, Veronique [Auteur]
Environnement périnatal et croissance - EA 4489 [EPS]
Ramdane, Nassima [Auteur]
Ghesquière, Louise [Auteur]
Delsalle, Anne [Auteur]
Coulon, Capucine [Auteur]
Subtil, Damien [Auteur] refId
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Vaast, Pascal [Auteur]
Garabedian, Charles [Auteur] refId
Journal title :
Transfusion
Abbreviated title :
Transfusion
Publication date :
2018-03-06
ISSN :
1537-2995
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
The antibody primarily responsible for fetal anemia may influence treatment and prognosis. The primary objective was to compare ante- and postnatal management and the outcomes of maternal red blood cell (RBC) alloimmunizations ...
Show more >
The antibody primarily responsible for fetal anemia may influence treatment and prognosis. The primary objective was to compare ante- and postnatal management and the outcomes of maternal red blood cell (RBC) alloimmunizations according to the antibody involved. The secondary objective was to compare anti-D alloimmunizations according to associated number of antibodies. A single-center study from 1999 to 2015 including maternal RBC alloimmunizations requiring intrauterine transfusion (IUT) was conducted. Patients were classified according to the antibody involved: anti-D, other Rh (anti-c and anti-E), and anti-K1. Obstetric data, IUT characteristics, and neonatal outcome were compared. A specific study on the anti-D, when isolated or associated, was then conducted. There were 106 pregnancies included, with 77.4% having anti-D, 9.4% having another anti-Rh (Rh group), and 13.2% having anti-K1. No significant difference between the anti-D and Rh groups was found for management and prognosis. The hemoglobin level in the first IUT was higher in the anti-D group than in the Kell group (6.8 vs. 4.7 g/dL, p = 0.008). Newborns in the anti-D group had significantly higher bilirubin levels and phototherapy duration than those in the Kell group. The mean estimated daily decrease in hemoglobin and that between the first two IUTs were lower with an isolated anti-D, compared with anti-D associated with two antibodies (p = 0.04). Anti-K1 alloimmunizations seem to cause more severe fetal anemia than anti-D alloimmunizations. Moreover, a decrease in hemoglobin appears to be more rapid when anti-D is associated with other antibodies.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
Université de Lille
Collections :
  • Environnement Périnatal et Santé - ULR 4489
  • METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Submission date :
2019-12-09T16:49:04Z
Université de Lille

Mentions légales
Université de Lille © 2017